Corynoxeine is primarily studied for its potential therapeutic effects in neurological and metabolic disorders. Research suggests it may exhibit neuroprotective properties, making it a candidate for treating neurodegenerative diseases like Parkinson's and Alzheimer's. It has also been investigated for its role in promoting autophagy, a cellular process that helps clear damaged cells and supports cellular health. Additionally, Corynoxeine shows promise in regulating glucose metabolism, which could be beneficial for managing diabetes. Its anti-inflammatory and antioxidant properties further contribute to its potential in mitigating oxidative stress-related conditions. Ongoing studies aim to explore its efficacy and safety for clinical applications.